Jon Moore

 Jon Moore
Jon Moore
CSO/ VP Oncology
Horizon Discovery
Speaker

Presentations at Drug Discovery 2015

Wed2  Sep09:10am(5 mins)
Session Chair Introduction

Session: Target Identification & Validation
Room: To be announced
Wed2  Sep03:00pm(30 mins)
The Impact of CRISPR/Cas9 on Target Identification and Validation

Session: Target Identification & Validation
Room: To be announced

Profile of Jon Moore

Jon Moore is CSO at Horizon and has been leading Horizon’s Target Validation and Drug Discovery efforts since late 2012. Prior to this, he enjoyed 10 years at Vernalis culminating in a role as Head of Biology, where he was responsible for cell biology, assay development and a management of a major research alliance with GSK. Jon’s research interests include cancer metabolism & signal transduction. His postdoctoral research focused on cell cycle control, first with Sally Kornbluth at Duke and then Nobel Prize winner, Tim Hunt, at Cancer Research UK’s Clare Hall labs. He holds a PhD from the University of Newcastle upon Tyne and is a Fellow of the Royal Society of Biology.

Colleagues

DeFranco
Delegate
Mrs Laura DeFranco
Business Development Manager
Horizon Discovery
DeFranco
Exhibitor
Mrs Laura DeFranco
Business Development
Horizon Discovery
Jowett
Exhibitor
Mr Mike Jowett
Business Development
Horizon Discovery
Tyacke
Exhibitor
Mr Sean Tyacke
Business Development
Horizon Discovery
Email
Please login to send a Private Message

Hosted By
ELRIG
The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App
Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
iPhone App
Android App
www.myeventflo.com/1791
Eventflo Home
copyright ELRIG, eventflo, Labhoo Ltd 2018